Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
Welcome to the Walk4CMT Toolbox
Welcome to the Walk4CMT Toolbox We are grateful that you have taken on a Walk 4 CMT event! This timeline will help you organize and promote your event, give you…
CMTA-STAR Advisory Board Member Dr. D’Antonio Publishes in Brain, Identifies Potential Therapeutic Target for CMT1B
…therapeutic target not only for CMT1B but also for other demyelinating forms of CMT, including CMT1A and CMT1E. In CMT1B, mutations in the MPZ gene can cause Schwann cells, which…
Gene Therapy Advances for CMT4J, CMT4A and GAN
…CMT, Giant Axonal Neuropathy (GAN), CMT4J, and CMT4A. The treatment for GAN has been in human clinical trials since 2015, the work for CMT4J is moving toward a human clinical…
CMTA-STAR Awards $1.1 Million for CMT1X, CMT2A Clinical Trials
…March 23 aimed at helping top CMT scientists prepare for clinical trials for CMT1X and CMT2A. CMT is a degenerative neuromuscular disease that kills the long, or peripheral, nerves to…
CMT_Survivors_Guide
Pete Foley Joins CMTA Board of Directors
Glenolden, PA, June 21, 2021—The Charcot-Marie-Tooth Association (CMTA), the national patient advocacy organization leading CMT research, today announced the appointment of Pete Foley to its Board of Directors. Originally from…
Gene Therapy for CMT1A, 1B, and X1: Progress in Nanoparticles
…the use of nanoparticles to deliver gene therapies directly to Schwann cells to treat CMTX1 (aka CMTX1, CMTX), the second most common type of CMT. This research focuses on using…
CMTA Announces New Center of Excellence in Kentucky
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of research aimed at bringing treatments to patients and improving the lives of those living with Charcot-Marie-Tooth disease (CMT), is excited…
CMTA Announces New Center of Excellence at Virginia Commonwealth University
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of research aimed at bringing treatments to patients and improving the lives of those living with Charcot-Marie-Tooth disease (CMT), is proud…